Akebia Therapeutics, Inc. (Nasdaq:AKBA)
Health Care/Life Sciences • Pharmaceuticals
CIK 1517022
Company
Akebia Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapeutics for patients with kidney diseases. The firm is also involved in the development and commercialization of drugs for the treatment of renal and metabolic disorders. Its products include Auryxia and Vadadustat. The company was founded by Joseph H. Gardner, John M. Rice, Michael E. Pape, Josh P. Fairbank, and Robert A. Shalwitz on February 27, 2007 and is headquartered in Cambridge, MA.
Address
245 First Street
Suite 1400
Cambridge, Massachusetts 02142
245 First Street
Suite 1400
Cambridge, Massachusetts 02142
Employees
167
167
Stock Info
Close
$1.8550
$1.8550
Day Range
1.8100 - 1.8600
1.8100 - 1.8600
52 Week Range
0.8000 - 2.4800
0.8000 - 2.4800
Average volume
2.19M
2.19M
Short Interest
14.98M (02/14/25)
14.98M (02/14/25)
% of Float Shorted
7.15%
7.15%
Market Cap
$404.73M
$404.73M
Revenue
$194.62M
$194.62M
Net Income
-$51.93M
-$51.93M
2020 Sales Growth
N/A
N/A
Key Executives
Board Of Directors
Chairman Adrian Adams |
Independent Director Ronald E. Frieson |
Independent Director Steven C. Gilman |
Independent Director Michael W. Rogers |
Independent Director LeAnne M. Zumwalt |
Independent Director Cynthia Smith |
Independent Director Myles Wolf |
SEC filings
Date | Form | Event |
---|---|---|
8 Nov, 2024 | SC 13G | |
7 Nov, 2024 | 8-K | |
7 Nov, 2024 | 10-Q | |
22 Oct, 2024 | 8-K | |
22 Oct, 2024 | SC 13G | |
16 Oct, 2024 | 8-K | |
12 Sep, 2024 | EFFECT | |
10 Sep, 2024 | CORRESP | |
9 Sep, 2024 | UPLOAD | |
3 Sep, 2024 | S-3 | |
8 Aug, 2024 | 10-Q | |
8 Aug, 2024 | 8-K | |
11 Jul, 2024 | 8-K | |
2 Jul, 2024 | 4 | |
26 Jun, 2024 | 3 | |
24 Jun, 2024 | 8-K | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 8-K | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
10 Jun, 2024 | 4 | |
14 May, 2024 | 4 | |
14 May, 2024 | 4 | |
13 May, 2024 | 144 | |
13 May, 2024 | 144 | |
9 May, 2024 | 10-Q | |
9 May, 2024 | 8-K | |
9 May, 2024 | 4 | |
25 Apr, 2024 | DEFA14A | |
25 Apr, 2024 | DEF 14A | |
25 Apr, 2024 | ARS | |
23 Apr, 2024 | 8-K | |
16 Apr, 2024 | 8-K | |
28 Mar, 2024 | 8-K | |
15 Mar, 2024 | 8-K | CEO Change |
14 Mar, 2024 | 10-K | |
14 Mar, 2024 | 8-K | |
1 Mar, 2024 | 4 | |
1 Mar, 2024 | 4 | |
1 Mar, 2024 | 4 | |
1 Mar, 2024 | 4 | |
29 Feb, 2024 | 4 | |
29 Feb, 2024 | 144 | |
29 Feb, 2024 | 144 | |
29 Feb, 2024 | 144 | |
29 Feb, 2024 | 144 | |
29 Feb, 2024 | 4 | |
29 Feb, 2024 | 4 | |
29 Feb, 2024 | 4 | |
27 Feb, 2024 | 144 | |
27 Feb, 2024 | 144 | |
27 Feb, 2024 | 144 | |
27 Feb, 2024 | 144 | |
13 Feb, 2024 | 8-K | |
13 Feb, 2024 | SC 13G/A | |
9 Feb, 2024 | SC 13G/A | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
2 Feb, 2024 | 4 | |
1 Feb, 2024 | 144 | |
1 Feb, 2024 | 144 | |
30 Jan, 2024 | 8-K | |
30 Jan, 2024 | S-8 | |
18 Jan, 2024 | 3 | |
18 Jan, 2024 | 3 | |
8 Jan, 2024 | 8-K | |
8 Jan, 2024 | 8-K | |
18 Dec, 2023 | 8-K | |
21 Nov, 2023 | 8-K | |
8 Nov, 2023 | 8-K | |
8 Nov, 2023 | 10-Q | |
2 Nov, 2023 | 8-K | |
25 Oct, 2023 | 8-K | |
12 Oct, 2023 | 8-K | |
26 Sep, 2023 | 8-K | |
28 Aug, 2023 | 10-K/A | |
28 Aug, 2023 | 10-Q | |
25 Aug, 2023 | 8-K | |
17 Aug, 2023 | 8-K | |
11 Aug, 2023 | 8-K | |
10 Aug, 2023 | NT 10-Q | |
1 Aug, 2023 | 8-K | |
1 Aug, 2023 | 4 | |
18 Jul, 2023 | 8-K | |
18 Jul, 2023 | 3 | |
13 Jun, 2023 | 8-K | CEO Change |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 4 | |
8 Jun, 2023 | 8-K | |
8 Jun, 2023 | 4 | |
7 Jun, 2023 | 8-K | |
6 Jun, 2023 | S-8 | |
2 Jun, 2023 | 8-K | |
31 May, 2023 | 8-K | |
30 May, 2023 | 8-K | |
25 May, 2023 | 4 | |
25 May, 2023 | 144 | |
25 May, 2023 | 144 | |
25 May, 2023 | 8-K | |
25 May, 2023 | 4 | |
23 May, 2023 | 8-K | |
18 May, 2023 | 4 | |
18 May, 2023 | 4 | |
16 May, 2023 | 4 | |
16 May, 2023 | 144 | |
16 May, 2023 | 144 | |
16 May, 2023 | 4 | |
9 May, 2023 | 8-K | |
8 May, 2023 | 10-Q | |
8 May, 2023 | 8-K | |
8 May, 2023 | 8-K | |
28 Apr, 2023 | DEF 14A | |
28 Apr, 2023 | ARS | |
28 Apr, 2023 | 8-K | |
25 Apr, 2023 | 8-K | |
21 Apr, 2023 | DEFA14A | |
14 Apr, 2023 | DEFA14A | |
14 Apr, 2023 | DEFA14A | |
11 Apr, 2023 | 8-K | |
11 Apr, 2023 | DEFA14A | |
31 Mar, 2023 | DEFA14A | |
27 Mar, 2023 | DEFA14A | |
27 Mar, 2023 | DEFA14A | |
27 Mar, 2023 | DEFA14A | |
24 Mar, 2023 | DEFA14A | |
17 Mar, 2023 | DEFR14A | |
10 Mar, 2023 | 10-K | |
9 Mar, 2023 | 8-K | |
3 Mar, 2023 | 4 | |
3 Mar, 2023 | 4 | |
3 Mar, 2023 | 4 | |
3 Mar, 2023 | 4 | |
3 Mar, 2023 | 4 | |
2 Mar, 2023 | 8-K | |
1 Mar, 2023 | 4 | |
1 Mar, 2023 | DEF 14A | |
1 Mar, 2023 | 4 | |
1 Mar, 2023 | 4 | |
1 Mar, 2023 | 4 | |
1 Mar, 2023 | 4 | |
21 Feb, 2023 | 8-K | |
17 Feb, 2023 | PRE 14A | |
10 Feb, 2023 | SC 13G/A | |
9 Feb, 2023 | SC 13G/A | |
2 Feb, 2023 | 4 | |
2 Feb, 2023 | 4 | |
2 Feb, 2023 | 4 | |
30 Jan, 2023 | S-8 | |
20 Jan, 2023 | SC 13G/A | |
9 Jan, 2023 | 8-K | |
28 Dec, 2022 | 8-K | |
19 Dec, 2022 | SC 13G | |
15 Dec, 2022 | 8-K | |
13 Dec, 2022 | CT ORDER | |
10 Nov, 2022 | 8-K | |
8 Nov, 2022 | 8-K | |
3 Nov, 2022 | 8-K | |
3 Nov, 2022 | 10-Q | |
7 Oct, 2022 | CT ORDER | |
1 Sep, 2022 | 4 | |
4 Aug, 2022 | 8-K | |
4 Aug, 2022 | 10-Q | |
18 Jul, 2022 | 8-K | |
8 Jul, 2022 | SC 13G | |
30 Jun, 2022 | 8-K | |
10 Jun, 2022 | 8-K | |
10 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | SC 13G/A | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
9 Jun, 2022 | 4 | |
7 Jun, 2022 | 4 | |
16 May, 2022 | 4 | |
16 May, 2022 | 4 | |
13 May, 2022 | 8-K | |
9 May, 2022 | 8-K | |
9 May, 2022 | 10-Q | |
28 Apr, 2022 | DEFA14A | |
28 Apr, 2022 | DEF 14A | |
28 Apr, 2022 | EFFECT | |
7 Apr, 2022 | 424B5 | |
7 Apr, 2022 | 424B5 | |
7 Apr, 2022 | 8-K | |
7 Apr, 2022 | 8-K | |
30 Mar, 2022 | 8-K | |
18 Mar, 2022 | CT ORDER | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
2 Mar, 2022 | 4 | |
1 Mar, 2022 | POSASR | |
1 Mar, 2022 | 10-K | |
1 Mar, 2022 | POS AM | |
1 Mar, 2022 | 8-K | |
22 Feb, 2022 | 8-K | |
18 Feb, 2022 | 4/A | |
10 Feb, 2022 | SC 13G/A | |
9 Feb, 2022 | SC 13G/A | |
7 Feb, 2022 | SC 13G/A | |
28 Jan, 2022 | S-8 | |
24 Jan, 2022 | 8-K | |
5 Jan, 2022 | 4 | |
30 Dec, 2021 | CT ORDER | |
15 Dec, 2021 | 8-K/A | |
4 Nov, 2021 | 10-Q | |
4 Nov, 2021 | 8-K | |
3 Nov, 2021 | 3 | |
3 Nov, 2021 | 4 | |
1 Nov, 2021 | 8-K | |
1 Oct, 2021 | 4 | |
28 Sep, 2021 | 8-K | |
9 Sep, 2021 | 8-K | |
2 Sep, 2021 | 4 | |
24 Aug, 2021 | 8-K | |
10 Aug, 2021 | SC 13G/A | |
5 Aug, 2021 | 8-K | |
5 Aug, 2021 | 10-Q | |
12 Jul, 2021 | SC 13G/A | |
9 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
3 Jun, 2021 | 8-K | |
3 Jun, 2021 | 4 | |
3 Jun, 2021 | 4 | |
1 Jun, 2021 | 8-K | |
10 May, 2021 | 10-Q | |
10 May, 2021 | 8-K | |
22 Apr, 2021 | DEF 14A | |
22 Apr, 2021 | DEFA14A | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
1 Apr, 2021 | 4 | |
30 Mar, 2021 | 8-K | |
18 Mar, 2021 | 4 | |
18 Mar, 2021 | 4 | |
18 Mar, 2021 | 4 | |
18 Mar, 2021 | 4 | |
18 Mar, 2021 | 4 | |
18 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
2 Mar, 2021 | 4 | |
25 Feb, 2021 | 8-K | |
25 Feb, 2021 | 10-K | |
25 Feb, 2021 | S-3ASR | |
18 Feb, 2021 | 8-K | |
18 Feb, 2021 | 3 | |
18 Feb, 2021 | 4 | |
17 Feb, 2021 | 8-K | |
12 Feb, 2021 | SC 13G/A | |
11 Feb, 2021 | SC 13G | |
10 Feb, 2021 | SC 13G | |
10 Feb, 2021 | SC 13G/A | |
3 Feb, 2021 | SC 13G/A | |
29 Jan, 2021 | SC 13G/A | |
28 Jan, 2021 | 8-K | |
28 Jan, 2021 | 3 | |
22 Jan, 2021 | S-8 | |
12 Jan, 2021 | 8-K |
Last update:2025-03-06 12:26:47.944507
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.